21 – 30 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP
- Contribution to journal › Article
-
Mark
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults
- Contribution to journal › Article
-
Mark
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
- Contribution to journal › Article
- 2023
-
Mark
Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics
- Contribution to journal › Article
-
Mark
Clusters based on immune markers in a Lithuanian asthma cohort study
- Contribution to journal › Article
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
- Contribution to journal › Letter
-
Mark
Multidisciplinary approaches to identifying and managing global airways disease : Expert recommendations based on qualitative discussions
- Contribution to journal › Article
-
Mark
Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis
- Contribution to journal › Article
-
Mark
Lung Fibroblasts from Chronic Obstructive Pulmonary Disease Subjects Have a Deficient Gene Expression Response to Cigarette Smoke Extract Compared to Healthy
- Contribution to journal › Article
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
- Contribution to journal › Article
